Long-term results with radiation therapy for pediatric desmoid tumors

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 5, 2000, Pages 1267-1271

  Merchant, Thomas E ^a   Nguyen, Duyen ^a   Walter, Andrew W ^b   Pappo, Alberto S ^a   Kun, Larry E ^a   Rao, Bhaskar N ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Aggressive; Desmoid tumors; Fibromatosis; Pediatrics; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; TAMOXIFEN; THIOTEPA; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DEATH; DESMOID TUMOR; FEMALE; FIBROSIS; FOLLOW UP; HEART FAILURE; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034662332     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00566-6     Document Type: Article

References (29)

1. Sherman N.E., Romsdahl M., Evans H., et al. Desmoid tumors A 20-year radiotherapy experience . Int J Radiat Oncol Biol Phys. 19:1990;37-40.
2. Spear M.A., Jennings L.C., Mankin H.J., et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 40:1998;637-645.
3. Stockdale A.D., Cassoni A.M., Coe M.E., et al. Radiotherapy and conservative surgery in the management of musculo-aponeurotic fibromatosis. Int J Radiat Oncol Biol Phys. 15:1988;851-857.
4. Easter D.W., Halasz N.A. Recent trends in the management of desmoid tumors. Ann Surg. 210:1989;765-769.
5. Zelefsky M.J., Harrison L.B., Shiu M.H., et al. Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumors. Cancer. 67:1991;380-384.
6. Rao B.N., Horowitz M.E., Parham D.M., et al. Challenges in the treatment of childhood fibromatosis. Arch Surg. 122:1987;1296-1298.
7. Faulkner L.B., Hajdu S.I., Kher U., et al. Pediatric desmoid tumor Retrospective analysis of 63 cases . J Clin Oncol. 13:1995;2813-2818.
8. Reitamo J.J., Scheinin T.M., Hayry P. The desmoid syndrome New aspects in the cause, pathogenesis and treatment of the desmoid tumor . Am J Surg. 151:1986;230-237.
9. Romero J.A., Kim E.E., Chung C.-G., et al. Different biologic features of desmoid tumors in adult and juvenile patients MR demonstration . J Comput Assist Tomogr. 19:1995;782-787.
10. Kiel K.D., Suit H.D. Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer. 54:1984;2051-2055.
11. Leibel S.A., Wara W.M., Hill D.R., et al. Desmoid tumors Local control and patterns of relapse following radiation therapy . Int J Radiat Oncol Biol Phys. 9:1983;1167-1171.
12. Greenberg H.M., Goebel R., Weichselbaum R.R., et al. Radiation therapy in the treatment of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 7:1981;305-310.
13. Weiss A.J., Lackman R.D. Low-dose chemotherapy for desmoid tumors. Cancer. 64:1989;1192-1194.
14. Klein W.A., Miller H.H., Anderson M., et al. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer. 60:1987;2863-2868.
15. Waddell W.R., Kirsch W.M. Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg. 161:1991;416-421.
16. Häyry P., Scheinin T.M. The desmoid (Reitamo) syndrome Etiology, manifestations, pathogenesis, and treatment . Curr Probl Surg. 25:1988;233-320.
17. Kaplan E.S., Meier P. Non-parametric estimations from incomplete observations. Am Stat Assoc J. 53:1958;457-482.
18. Goy B.W., Lee S.P., Eilber F., et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys. 39:1997;659-665.
19. Keus R., Bartelink H. The role of radiotherapy in the treatment of desmoid tumours. Radiother Oncol. 7:1986;1-5.
20. Bataini J.P., Belloir C., Mazabraud A., et al. Desmoid tumors in adults The role of radiotherapy in their management . Am J Surg. 155:1988;754-760.
21. Ballo M.T., Zagars G.K., Pollack A. Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. 42:1998;1007-1014.
22. Hizawa K., Iida M., Mibu R., et al. Desmoid tumors in familial adenomatous polyposis/Gardner's Syndrome. J Clin Gastroenterol. 25:1997;334-337.
23. Luo M., Gomperts B., Imren S., et al. Differences in expression of matrix metalloproteinases, metalloproteinase inhibitors, and plasminogen activators in cultured ovarian cystadenomas, tumors and low-malignant potential, and carcinomas. Proc Annu Meet Am Assoc Cancer Res. 38:1997;A2764.
24. Afzal S., Lalani E.N., Polsom R., et al. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors Possible implications for the role of desmoplastic fibroblasts . Hum Pathol. 29:1998;155-165.
25. Yamamoto Y., Sawaya R., Mohanam S., et al. Expression of membrane-type matrix metalloproteinase and gelatinase A activation in human malignant glial tumors. Proc Annu Am Assoc Cancer Res. 37:1996;A3358.
26. Furukawa A., Tsuji M., Nishitani M., et al. Role of the matric metalloproteinase and tissue inhibitors of metalloproteinase familes in noninvasice and invasive tumors transplanted in mice with severe combined immunodeficiency. Urology. 51:1998;849-853.
27. Tagawa T., Ohse S., Hirano Y., et al. Aggressive infantile fibromatosis of the submandibular region. Intl J Oral Maxillofac Surg. 18:1989;264-265.
28. Murashige M., Miyahara M., Shiraishi N., et al. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol. 26:1996;303-309.
29. Goto Y., Nagasawa H., Sasaki T., et al. Biochemical changes during growth and regression of pregnancy-dependent mammary tumors of GR/A mice. Proc Soc Exp Biol Med. 209:1995;343-353.